Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Detroit | 7,247 Studies Near You

Clinical TrialsDetroit

Clinical Trials in Detroit

Discover 7,247 clinical trials near Detroit, Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5061-5080 of 7,247 trials

Active not recruitingCombination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic LymphomaThis randomized phase III trial compares how well combination chemotherapy works when given with or without bortezomib in treating patients with newly diagnosed T-cell acute…NCT02112916·Birmingham, Alabama and 211 others

Find Trials by Condition in Detroit

Breast Cancerin Detroit Lung Cancerin Detroit Prostate Cancerin Detroit Colorectal Cancerin Detroit Melanomain Detroit Leukemiain Detroit Lymphomain Detroit Pancreatic Cancerin Detroit Ovarian Cancerin Detroit Brain Cancerin Detroit Diabetes

Data from ClinicalTrials.govTerms

CompletedSafety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid TumorsThis Phase 1a/1b study will evaluate the safety, tolerability and the pharmacokinetics/pharmacodynamics (PK/PD) of KT-333 in Adult patients with Relapsed or Refractory (R/R)…NCT05225584·Orange, California and 12 others

CompletedS0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic SyndromeRATIONALE: Immunosuppressive therapy may improve bone marrow abnormalities and may be an effective treatment for myelodysplastic syndrome.NCT00016419·Mobile, Alabama and 93 others

CompletedSafety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) ImagingThis is a study involving the use of Magnetic Resonance Imaging (MRI) contrast agents called Gadavist.NCT00623467·Phoenix, Arizona and 36 others

CompletedStudy of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and NeckDalantercept, a soluble form of the activin receptor-like kinase-1 protein, is being studied in patients with squamous cell carcinoma of the head and neck (SCCHN).NCT01458392·Aurora, Colorado and 7 others

TerminatedPhase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple MyelomaThis study is a first-in-human, Phase 1/2, open label study that will evaluate safety and efficacy of ISB 1442 in relapsed/refractory multiple myeloma (R/R MM).NCT05427812·Miami, Florida and 14 others

Active not recruitingTesting the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic LeukemiaThis phase III trial compares adding a new anti-cancer drug (venetoclax) to the usual treatment (ibrutinib plus obinutuzumab) in older patients with chronic lymphocytic leukemia…NCT03737981·Birmingham, Alabama and 856 others

Active not recruitingA Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local TherapiesResearchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.NCT05794906·Phoenix, Arizona and 225 others

CompletedTrial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)This phase 3, double-blind, vehicle-controlled study assessed the safety and efficacy of roflumilast (ARQ-154) foam 0.3% applied once daily (qd) for 8 weeks by participants with…NCT04973228·Scottsdale, Arizona and 52 others

CompletedS0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00030433·Birmingham, Alabama and 101 others

CompletedA Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) AmyloidosisThe purpose of this study is to evaluate the efficacy and safety of daratumumab plus cyclophosphamide, bortezomib and dexamethasone (CyBorD) compared with CyBorD alone in…NCT03201965·Phoenix, Arizona and 139 others

CompletedEncouraging Young Adults to Make Effective Nutrition ChoicesThe purpose of this study is to conduct a two site, three arm randomized intervention study to improve fruit and vegetable intake, improve whole grain intake and reduce sweetened…NCT01979809·Detroit, Michigan and 1 other

CompletedPhase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple MyelomaThe purpose of the study is to determine whether the addition of Elotuzumab to Lenalidomide/low-dose Dexamethasone will increase the progression free survival (PFS)NCT01335399·Birmingham, Alabama and 234 others

RecruitingStent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement CollaborativeThis is a multicenter prospective trial with randomized and observational cohorts assessing patient-reported outcomes and unplanned healthcare utilization following ureteroscopic…NCT05866081·Tucson, Arizona and 15 others

CompletedA Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal CancerThe primary objective of the phase 1 portion of this study is to determine the recommended dose of bemarituzumab in combination with 5-fluorouracil, leucovorin and oxaliplatin…NCT03343301·Tucson, Arizona and 6 others

RecruitingA Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related DiseasesA Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia gravis (GMG).NCT06626919·Los Angeles, California and 12 others

CompletedA Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic CancerThe primary purpose of this study is to assess the safety and effectiveness of TNFerade™ Biologic when administered concurrently with 5-FU and radiation therapy as first-line…NCT00051467·La Jolla, California and 24 others

CompletedA Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular RosaceaThe primary objectives of this study are to determine the efficacy and safety of FMX103 1.5% minocycline foam applied topically once daily for 12 weeks in the treatment of rosacea.NCT04608500·Glendale, Arizona and 45 others

CompletedEfficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisThis study assessed the safety, tolerability and efficacy of two doses of oral fingolimod compared to placebo on efficacy parameters in patients with relapsing-remitting multiple…NCT00355134·Birmingham, Alabama and 111 others

RecruitingTesting Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian CancerThis phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination…NCT06580314·Birmingham, Alabama and 694 others

PreviousPage 254 of 363Next

in Detroit

Heart Diseasein Detroit